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Introduction {#embr201541532-sec-0001}
============

The Hedgehog (Hh) signalling pathway plays crucial roles in the embryonic development of most animals as well as in tissue homeostasis, metabolism and physiological processes in juveniles and adults. Accordingly, aberrant Hh pathway activity has been implicated in many human disorders including birth defects and cancers [1](#embr201541532-bib-0001){ref-type="ref"}. Hh ligands exert their functions principally through a signalling cascade that controls the balance between the activator and repressor forms of Gli family transcription factors. In the absence of Hh, these proteins are phosphorylated by cAMP‐dependent protein kinase (PKA), which promotes their partial cleavage by the proteasome, yielding C‐terminally truncated transcriptional repressors [2](#embr201541532-bib-0002){ref-type="ref"}, [3](#embr201541532-bib-0003){ref-type="ref"}, [4](#embr201541532-bib-0004){ref-type="ref"}. The binding of Hh ligand to its receptor, Patched (Ptch), relieves the inhibition of Smoothened (Smo), an atypical member of the G‐protein‐coupled receptor (GPCR) superfamily, and promotes its translocation to the plasma membrane in *Drosophila* [5](#embr201541532-bib-0005){ref-type="ref"}, or to the primary cilium (PC) in vertebrates [6](#embr201541532-bib-0006){ref-type="ref"}. Activated Smo prevents Gli cleavage and promotes the activation of its full‐length form, which induces transcription of Hh pathway target genes [1](#embr201541532-bib-0001){ref-type="ref"}. Exactly how Smo mediates the regulation of Gli activity is still not fully understood, but various studies highlight its interaction with the kinesin family member Kif7 [7](#embr201541532-bib-0007){ref-type="ref"}. In addition, recent analyses have implicated classical GPCR signalling pathways in modulating Gli activity [8](#embr201541532-bib-0008){ref-type="ref"}, [9](#embr201541532-bib-0009){ref-type="ref"}, [10](#embr201541532-bib-0010){ref-type="ref"}.

G‐protein‐coupled receptor kinases (GRKs) play important roles in desensitisation of activated GPCRs by directly phosphorylating their C‐terminal tails (CTTs), thereby promoting the recruitment of β‐arrestin to mediate internalisation of the activated receptors [11](#embr201541532-bib-0011){ref-type="ref"}. Several studies have implicated GRK2 as a positive regulator of the Hh pathway [12](#embr201541532-bib-0012){ref-type="ref"}, [13](#embr201541532-bib-0013){ref-type="ref"}, [14](#embr201541532-bib-0014){ref-type="ref"}. The depletion of GRK2 by RNA interference in tissue culture cells leads to a downregulation of Hh activity [14](#embr201541532-bib-0014){ref-type="ref"}, an effect recapitulated by morpholino‐mediated knock‐down of *grk2* in zebrafish embryos [13](#embr201541532-bib-0013){ref-type="ref"}. Further studies have suggested that GRK2 is essential for promoting Hh pathway activity by direct phosphorylation of Smo, which is also phosphorylated by casein kinase 1 (CK1) in vertebrates and by PKA in *Drosophila* [15](#embr201541532-bib-0015){ref-type="ref"}, [16](#embr201541532-bib-0016){ref-type="ref"}, [17](#embr201541532-bib-0017){ref-type="ref"}. Such a role for Grk2 in potentiating the activity of Smo contrasts with its canonical function in GPCR desensitisation.

Here, we have re‐examined the role of Grk2 function in Hh signalling by using targeted mutagenesis to eliminate its activity completely from both zebrafish embryos and cultured mammalian cells. We show that Grk2 plays a critical role in Hh signal transduction upstream of the Gli transcription factors, but downstream of Smo both in mammalian cells and in the zebrafish embryo and that maternally supplied Grk2 is sufficient to support Hh signalling during the early stages of zebrafish development. We also show that localisation of Smo to the PC is independent of Grk2 in both zebrafish and mammalian cells. In addition, we present evidence that in zebrafish embryos, phosphorylation of putative GRK2 sites in the Smo CTT is neither necessary nor sufficient for Hh pathway activation. Our results suggest that Grk2 functions as a positive regulator of Hh signalling, not by direct phosphorylation of Smo but by regulation of a more distal step in the pathway.

Results {#embr201541532-sec-0002}
=======

Generation of a mutant allele of zebrafish *grk2* using zinc finger nucleases {#embr201541532-sec-0003}
-----------------------------------------------------------------------------

Mammalian genomes contain two paralogous genes, *Grk2* and *Grk3* that encode closely related proteins. By contrast, BLAST searches of the zebrafish genome revealed a single gene, designated *grk2*, the predicted protein sequence of which is more similar to that of mammalian GRK3 (Fig [1](#embr201541532-fig-0001){ref-type="fig"}A). Previous functional analyses of this gene have relied upon morpholino‐mediated transient gene knock‐down in zebrafish embryos [14](#embr201541532-bib-0014){ref-type="ref"}, an approach that has well‐documented limitations [18](#embr201541532-bib-0018){ref-type="ref"}. To investigate the effects of complete loss of Grk2 function, a null allele of the zebrafish *grk2* gene was generated using zinc finger nuclease (ZFN)‐mediated targeted mutagenesis. The ZFN recognition site was designed to target the end of the first exon of the gene (Fig [1](#embr201541532-fig-0001){ref-type="fig"}B). The mutagenesis rate was relatively low (\< 5%), yielding only a single *grk2* mutant allele, designated *grk2* ^*i283*^. This mutation is the result of a single base pair (C--G) deletion at coding sequence (CDS) 111, 111delC, causing a frame shift predicted to lead to a 72 residue C‐terminally truncated protein containing only 37 out of the 688 amino acids that comprise Grk2. As shown in Fig [1](#embr201541532-fig-0001){ref-type="fig"}C, the truncated region includes most of the regulator of G‐protein signalling (RGS) domain, the entire kinase domain and the Pleckstrin homology (PH) domain; since these are all important functional domains of the protein, *grk2* ^*i283*^ is likely to be a null allele. Animals homozygous for *grk2* ^*i283*^ obtained by in‐crossing adult heterozygotes completed embryogenesis and showed no defects in specification of neuronal or muscle fibre cell types, both of which depend upon Hh pathway activity in zebrafish [19](#embr201541532-bib-0019){ref-type="ref"}, [20](#embr201541532-bib-0020){ref-type="ref"}. By 4dpf (days post‐fertilisation), however, the mutant larvae had failed to form a normal swim bladder (*n* = 16), an organ known to be Hh dependent [21](#embr201541532-bib-0021){ref-type="ref"}. This phenotype is thus consistent with a late developmental requirement for Grk2 in Hh signalling; no homozygous animals survived beyond 20dpf (Fig [1](#embr201541532-fig-0001){ref-type="fig"}D).

![Generation of a zebrafish *grk2* null mutation\
Phylogenic tree showing the relationship of the various vertebrate *Grk* genes and the *Drosophila gprk* gene.Schematic representation of the exon 1 nucleotide sequence of zebrafish *grk2* gene targeted by the ZFN.Schematic representation of the zebrafish Grk2 protein domains and the truncated peptide predicted to be encoded by the *grk2* ^*i283*^ mutant allele.Homozygous *grk2* ^*i283*^ mutant at 4dpf compared to wild type (WT) sibling (*N* = 80). Arrows indicate the position of swim bladder. Scale bar, 1 mm.](EMBR-17-739-g002){#embr201541532-fig-0001}

Grk2 activity is essential for the response to Hh signals {#embr201541532-sec-0004}
---------------------------------------------------------

The lack of obvious early developmental defects indicative of a loss of Hh pathway activity in *grk2* ^*i283*^ homozygotes contrasts with the previously reported effects on muscle cell‐type specification caused by morpholino‐mediated knock‐down of *grk2* (Fig [EV1](#embr201541532-fig-0001ev){ref-type="fig"}) [14](#embr201541532-bib-0014){ref-type="ref"}. Translation‐blocking morpholinos can inhibit maternally as well as zygotically expressed mRNA and maternally derived *grk2* has previously been shown to be present in newly fertilised eggs [22](#embr201541532-bib-0022){ref-type="ref"}. To investigate the activity of maternally derived Grk2 protein, chimeric fish carrying *grk2* homozygous mutant germ lines were generated using the established germ cell transplantation technique [23](#embr201541532-bib-0023){ref-type="ref"}. Maternal‐zygotic (MZ) mutant embryos generated by crossing chimeric females to chimeric males lacked all Grk2 protein, as revealed by Western blot analysis (Fig [2](#embr201541532-fig-0002){ref-type="fig"}A): strikingly, these embryos displayed a curved body axis, U‐shaped somites and severe cyclopia, a phenotype almost indistinguishable from that of *smo* homozygous mutants [24](#embr201541532-bib-0024){ref-type="ref"} (Fig [2](#embr201541532-fig-0002){ref-type="fig"}B). At 24hpf (hours post‐fertilisation), the levels of mRNA encoded by *Ptch2*, a direct target of Hh pathway activity, were substantially reduced in both the mesoderm and the neural tube of MZ*grk2* embryos, as judged by *in situ* hybridisation (Fig [2](#embr201541532-fig-0002){ref-type="fig"}C). Similarly, *nkx2.2a* and *olig2* transcripts, markers of V3 interneurons and motor neurons, respectively, were below the levels of detection in both the neural tube and brain (Fig [2](#embr201541532-fig-0002){ref-type="fig"}C). Like *smo* mutants, the MZ*grk2* embryos displayed a dramatic loss of Hh‐dependent muscle cell types at 30hpf (Figs [2](#embr201541532-fig-0002){ref-type="fig"}D and [EV1](#embr201541532-fig-0001ev){ref-type="fig"}): the myotomes were devoid of all Eng‐expressing muscle pioneers (MPs) and medial fast‐twitch fibres (MFFs), while Prox1^+ve^ superficial slow‐twitch fibres (SSFs) were absent from all but the most anterior somites, where, in contrast to *smo* mutants, a few SFFs (1 ± 1 per somite) were present (Fig [EV1](#embr201541532-fig-0001ev){ref-type="fig"}). Injection of mRNA encoding GFP‐tagged wild‐type Grk2 (*grk2‐GFP)* into MZ*grk2* embryos efficiently suppressed the mutant phenotype (100%; *N* = 50) and fully recovered all Hh‐dependent gene expression and muscle cell types (Figs [2](#embr201541532-fig-0002){ref-type="fig"}C and D, and [EV1](#embr201541532-fig-0001ev){ref-type="fig"}).

![MZ*grk2* shows severe Hh defects\
Numbers of Prox1a^+ve^ cells in wild‐type (WT), zygotic *grk2* mutants, MZ*grk2*, MZ*grk2* injected with Grk2‐GFP and Grk2 ATG morphant embryos at 30hpf (*n* = 8). The error bars indicate SD. Asterisks indicate statistically significant differences based on unpaired Student\'s *t*‐test. \*\*\*\**P* \< 0.0001.](EMBR-17-739-g003){#embr201541532-fig-0001ev}

![Loss of Grk2 impairs Hh signal transduction in zebrafish\
Western blot analysis of the different forms of Gli2a in MZ*grk2* embryos compared to wild‐type (AB), *shh* mRNA‐ and *dnPKA* mRNA‐injected wild‐type and cyclopamine (Cyc(A))‐treated wild‐type 20hpf embryos. Gli2a‐FL levels are low relative to Gli2aR levels in wild‐type embryos, but are elevated in response to pathway activation (*shh* and *dnPKA* mRNA injected). Gli2aR levels are increased while Gli2a‐FL is undetectable in CycA‐treated and MZ*grk2* mutant embryos. Probing the same blot with rabbit anti‐GRK3 (which recognises the zebrafish Grk2 protein) reveals a complete loss of full‐length Grk2 in MZ*grk2* embryos. Probing with anti‐γ‐tubulin was performed as a loading control. Three biological replicates of this analysis were performed.Phenotype of wild‐type (WT), MZ*grk2* and *grk2‐GFP* mRNA‐injected MZ*grk2* embryos at 24hpf (*n* = 20 for each sample). The red lines indicate the shape of the somites (middle panels) and the separation of the eyes (right hand panels). Scale bar, 200 μm.*In situ* hybridisation of *ptch2*,*nkx2.2a* and *olig2* transcripts in wild‐type, MZ*grk2*‐and *grk2‐GFP*‐injected MZ*grk2* 24hpf embryos. Each panel shows a full view of the embryo on the left and a cross‐sectional view of a somite on the right (*n* = 30 for each sample). Scale bars, 200 μm (whole mounts), 50 μm (sections).Expression of Prox1a and Engrailed (Eng) proteins in somites of wild‐type, MZ*grk2*‐ and *grk2‐GFP* mRNA‐injected MZ*grk2* embryos at 30hpf. Each panel shows Prox1a in green, Eng in red and the merged images with DAPI staining in blue (*n* = 10 for each sample). Scale bar, 50 μm.](EMBR-17-739-g004){#embr201541532-fig-0002}

Hh pathway activity modulates the PKA‐dependent processing of the Gli2 and Gli3 transcription factors: in the zebrafish, ubiquitous activation of the pathway by ectopic Shh expression or inhibition of PKA activity leads to accumulation of the full‐length activator form of Gli2a, whilst Smo inhibition by cyclopamine (CycA) promotes production of its truncated repressor form at the expense of the full‐length activator form [25](#embr201541532-bib-0025){ref-type="ref"}, [26](#embr201541532-bib-0026){ref-type="ref"} (Fig [2](#embr201541532-fig-0002){ref-type="fig"}A). Consistent with the phenotypic similarities to *smo*, Western blot analysis revealed a loss of full‐length Gli2a and accumulation of its truncated repressor form in MZ*grk2* embryos (Fig [2](#embr201541532-fig-0002){ref-type="fig"}A).

Grk2 modulates Hh pathway upstream of Gli processing {#embr201541532-sec-0005}
----------------------------------------------------

To investigate at which point in the transduction of the Hh signal Grk2 is required, the pathway was activated at three different levels by injection of mRNA encoding either: (i) the Shh ligand; (ii) an oncogenic mutant form of Smo, SmoA1 [27](#embr201541532-bib-0027){ref-type="ref"}; or (iii) a dominant negative form of the PKA regulatory subunit, dnPKA. Injection of each of these mRNAs into wild‐type embryos has similar effects, causing the transformation of most of the myotome into slow‐twitch muscle fibres and the ectopic expression of Eng [28](#embr201541532-bib-0028){ref-type="ref"}, [29](#embr201541532-bib-0029){ref-type="ref"}, [30](#embr201541532-bib-0030){ref-type="ref"} (Fig [3](#embr201541532-fig-0003){ref-type="fig"}A). Injection of *dnPKA* mRNA into MZ*grk2* mutant embryos similarly led to the widespread induction of slow‐twitch fibres and Eng expression (Fig [3](#embr201541532-fig-0003){ref-type="fig"}A). MZ*grk2* embryos injected with *shh* or *mSmoA1* mRNA, by contrast, showed strongly attenuated responses; only a few additional slow‐twitch fibres (3 ± 2 and 7 ± 4 per somite, *n* = 8) were detected scattered throughout the length of the trunk, in addition to those restricted to the anterior somites of uninjected controls (Fig [3](#embr201541532-fig-0003){ref-type="fig"}A). Consistent with these phenotypic effects, overexpressing Shh or mSmoA1 in MZ*grk2* failed to block production of the truncated repressor form of Gli2a (Fig [3](#embr201541532-fig-0003){ref-type="fig"}B).

![Grk2 acts upstream of Gli processing\
Prox1a and Eng expression in the myotome of 30hpf wild‐type (WT) and MZ*grk2* embryos injected with mRNAs encoding Shh, dnPKA or mSmoA1‐GFP. Each panel shows Prox1a in green, Eng in red and the merged images with DAPI staining in blue. The co‐labelling for Prox1a and Eng (orange) is indicative of MP differentiation (*n* = 30 for each sample). Scale bar, 50 μm.Western blot showing levels of Gli2a‐FL and Gli2a‐R forms in 20hpf wild‐type (WT) and MZ*grk2* (MZ) embryos injected with mRNA encoding Shh, dnPKA or mSmoA1‐GFP, respectively. γ‐tubulin was used as a loading control. Three biological replicates of this analysis were performed.](EMBR-17-739-g006){#embr201541532-fig-0003}

To extend the zebrafish analysis to mammalian cells, we used the lentiCRISPR‐Cas9 mutagenesis method to generate several clonal Flp‐In‐3T3 fibroblast cell lines lacking Grk2 (*Grk2* ^−/−^ cells). In wild‐type cells, SAG treatment caused an increase in Gli1 and Ptch1 protein and a decrease in Gli3 repressor levels; by contrast, the *Grk2* ^−/−^ cells did not respond to Shh or SAG (Fig [4](#embr201541532-fig-0004){ref-type="fig"}A and C). The defect in Hh responsiveness correlated with the amount of residual Grk2 protein in these cell lines (Fig [4](#embr201541532-fig-0004){ref-type="fig"}A). Overexpression of PKI, an inhibitor of PKA, in both wild‐type and *Grk2* ^−/−^ cells caused constitutively active pathway activity even without Hh ligand (Fig [4](#embr201541532-fig-0004){ref-type="fig"}B); however, as in zebrafish embryos, the constitutively active mutant mSmoA1 did not rescue pathway activation in *Grk2* ^−/−^ cells (Fig [4](#embr201541532-fig-0004){ref-type="fig"}C).

![Mammalian *Grk2* ^*−/−*^ cells exhibit strong loss of Hh signalling upstream of Gli processing\
AWestern blot analysis of GRK2, GLI1, PTCH1 and GLI3 protein levels in Flp‐In‐3T3 cells with lentiCRISPR of four different guide RNAs in the presence or absence of SAG. α‐tubulin was used as a loading control. Guide RNA 2 was found to remove Grk2 efficiently and used for subsequent experiments. GLI3 panel shows both full‐length (GLI3FL) and repressor form of GLI3 (GLI3R) (*n* = 3).B, CHh reporter activity assay for wild‐type and *Grk2* ^*−/−*^ cells. Cells were treated with PKA peptide inhibitor (PKI) and mutant form of PKA peptide inhibitor (PKI‐M), respectively, in the presence or absence of SHH (B). Cells were transfected with *mSmoA1‐GFP*‐expressing constructs in the presence of SHH or SAG (C). Data represent the mean and ± SD (*n* = 3). Unpaired Student\'s *t*‐test was used for analysis. \*\*\**P* \< 0.001; \*\**P* \< 0.01; \**P* \< 0.05 and n.s. (not significant).](EMBR-17-739-g008){#embr201541532-fig-0004}

Phosphorylation of the carboxyl terminal tail is not essential for Smoothened activation {#embr201541532-sec-0006}
----------------------------------------------------------------------------------------

That loss of Grk2 suppresses ectopic pathway activation caused by the SmoA1 mutation, is consistent with the view that Grk2‐dependent phosphorylation of the CTT of Smo is required for its activity. Indeed, previous studies using mammalian cell culture assays have reported that the constitutive activity of SmoA1 can be abolished by mutation of the putative CK1 and GRK2 phosphorylation sites in its CTT [16](#embr201541532-bib-0016){ref-type="ref"}. We found, however, that this mutant form, mSmoA1SA, retained constitutive activity in the zebrafish embryo, as evidenced by the increased numbers of Prox1^+ve^ and Eng^+ve^ fibres in the myotome (Fig [5](#embr201541532-fig-0005){ref-type="fig"}A and B). This effect cannot simply be accounted for by an increased stability of the mutated protein, as levels of mSmoA1SA in injected embryos were significantly lower than those of wild‐type mSmo expressed from injected mRNA (Fig [EV2](#embr201541532-fig-0002ev){ref-type="fig"}A). Notably, the increase in Prox1^+ve^ cells was less than that induced by mSmoA1 expression (Fig [5](#embr201541532-fig-0005){ref-type="fig"}A and B) whilst the ectopic Eng expression was restricted to fast‐twitch muscle fibres (Fig [5](#embr201541532-fig-0005){ref-type="fig"}A), indicating that mutation of the phosphorylation sites attenuates, but does not abolish, Smo activity. Consistent with this, quantitative PCR analysis revealed a less robust upregulation of *ptch2* transcription by mSmoA1SA compared to mSmoA1 (Fig [EV2](#embr201541532-fig-0002ev){ref-type="fig"}B).

![Phosphorylation of the CTT is not essential for Smo function\
Expression of Prox1a (green) and the *eng2a:GFP* reporter (red) in otherwise wild‐type 30hpf embryos injected with mRNA encoding wild‐type and mutant forms of mouse Smo (mSmo). Ectopic MPs are indicated by fibres co‐labelled with Proxa1 and GFP; ectopic MFFs are labelled only with GFP. Images are representative of embryos in the following proportions of each sample: 28/28 (mSmo; mSmoA1; mSmoSD; mSmoKRA); 9/28 (mSmoA1SA); and 12/28 (mSmoA1SD). Scale bar, 50 μm.Average number of Prox1a^+ve^ slow fibres in wild‐type embryos injected with mRNA encoding different forms of mSmo. Prox1‐positive cells were quantified in four somites in each of four embryos for each sample. The error bars indicate SD. Unpaired Student\'s *t*‐test was used to determine the statistical significance between uninjected embryos and the various Smo mutants (black asterisk) and between mSmoA1 and mSmoA1SA or mSmoA1SD (red asterisk). \*\*\**P* \< 0.001; \*\**P* \< 0.01; \**P* \< 0.05 and n.s. (not significant).Prox1a and Eng expression in *smo* ^*hi1640*^ mutant embryos injected with mRNA encoding mSmo (*n* = 10), mSmoSA (*n* = 9) and mSmo14SA (*n* = 6). Note the full recovery of SSFs and MPs compared to the uninjected controls. Scale bar, 50 μm.*In situ* hybridisation for transcripts of *ptch2*,*olig2* and *nkx2.2* in 24hpf *smo* ^*hi1640*^ mutant embryos injected with mRNA encoding mSmo and mSmoSA (*n* = 6 for each sample). Scale bars, 100 μm (lateral view), 50 μm (sections).Hh reporter assay of the activity of wild‐type and mutant forms of mSmo in *Smo* ^−/−^ MEFs in response to Shh or SAG stimulation. Note that mSmoA1 shows constitutive activity in the absence of either Shh or SAG, whereas mSmoKRA does not; all mutants affecting phosphorylation failed to restore the response to Shh or SAG. Data represent the mean and ± SD (*n* = 3). Unpaired Student\'s *t*‐test was used for analysis. \*\*\*\**P* \< 0.0001; \*\*\**P* \< 0.001; \*\**P* \< 0.01; and n.s. (not significant).](EMBR-17-739-g010){#embr201541532-fig-0005}

![Phosphorylation and dimerisation of Smo does not impair or enhance Hh activity\
Western blot analysis of wild‐type and mutant forms of Smo expressed from bicistronic myc‐tagged mSmo and GFP constructs injected into wild‐type zebrafish embryos. The histogram shows the quantification of Myc‐tagged mSmo vs. GFP (*n* = 3). The error bars indicate SD.Normalised expression of *ptch2* in 18hpf wild‐type (AB), Cyc(A)‐treated embryos and embryos injected with mRNA encoding Shh or various Smo mutants. Individual data points (blue crosses) are shown; mean is indicated by thick solid line, and SD by thin bars. Unpaired Student\'s *t*‐test was used to determine the statistical significance between control (AB) and experimental embryos. \*\*\**P* \< 0.001; \*\**P* \< 0.01; and n.s. (not significant).Prox1a and Eng expression in *smo* ^*hi1640*^ mutant embryos injected with mRNA encoding mSmoSD (*n* = 7) and mSmoKRA (*n* = 7). These mutant embryos show full recovery of SSFs and MPs. Embryos shown are at 30hpf. Scale bar, 50 μm.](EMBR-17-739-g005){#embr201541532-fig-0002ev}

By contrast to the constitutive activity of mSmoA1SA, a form of Smo containing phosphomimetic mutations of the predicted CTT phosphorylation sites, mSmoSD, showed no evidence of constitutive activity (Figs [5](#embr201541532-fig-0005){ref-type="fig"}A and B, and [EV2](#embr201541532-fig-0002ev){ref-type="fig"}B); this contrasts with the reported constitutive activity of this mutant form in cultured cells [16](#embr201541532-bib-0016){ref-type="ref"}. On the other hand, introduction of these phosphomimetic residues into mSmoA1 attenuated its activity to a similar degree as the S‐A mutations (Figs [5](#embr201541532-fig-0005){ref-type="fig"}A and B, and [EV2](#embr201541532-fig-0002ev){ref-type="fig"}B). To explore the potential significance of phosphorylation of the CTT further, we used a more stringent *smo* rescue assay to test the function of the mutant forms of mSmo [31](#embr201541532-bib-0031){ref-type="ref"}. In line with previous studies, we found that injection of mRNA encoding GFP‐tagged forms of mSmo completely restored the specification of Hh‐dependent cell types in the myotome of zebrafish *smo* mutants at 30hpf (Fig [5](#embr201541532-fig-0005){ref-type="fig"}C). Mutation of all the predicted phosphorylation sites in the mSmo CTT (mSmoSA) had no effect on the efficiency of rescue, as assayed by Prox1a and Eng expression (Fig [5](#embr201541532-fig-0005){ref-type="fig"}C) as well as the expression pattern of *ptch2, nkx2.2a* and *olig2* transcripts (Fig [5](#embr201541532-fig-0005){ref-type="fig"}D). We considered the possibility that other previously unidentified Grk2 sites might be sufficient to mediate Smo activation; based on the consensus Grk2 phosphorylation sites[32](#embr201541532-bib-0032){ref-type="ref"}, we identified two further putative sites within the mSmo CTT; mutagenesis of these additional sites in mSmoSA (mSmo14SA) did not affect the rescue efficiency (Fig [5](#embr201541532-fig-0005){ref-type="fig"}C).

Phosphorylation of the Smo CTT has been postulated to neutralise the positive charges caused by a cluster of lysine/arginine residues, thereby promoting dimerisation that promotes activation of pathway components downstream of Smo, a view supported by FRET‐based analysis of Smo conformation [16](#embr201541532-bib-0016){ref-type="ref"}. In line with this, replacement of the lysine and arginine cluster by alanines in mSmoKRA was reported to render the mutant protein constitutively active in tissue culture assays [16](#embr201541532-bib-0016){ref-type="ref"}. Expression of mSmoKRA in wild‐type zebrafish embryos, however, showed no evidence of constitutive pathway activity, although it could fully rescue the *smo* mutant phenotype (Figs [5](#embr201541532-fig-0005){ref-type="fig"}A and B, and [EV2](#embr201541532-fig-0002ev){ref-type="fig"}B and C).

In the light of these findings, we re‐examined the activity of these Smo mutant forms in mammalian tissue culture cells. In our hands, neither mSmoSD nor mSmoKRA showed any evidence of constitutive pathway activity (Fig [5](#embr201541532-fig-0005){ref-type="fig"}E). However, in contrast to the findings in zebrafish embryos, mutant forms refractory to phosphorylation, viz. mSmoSA and mSmoA1SA, failed to restore the response to Hh in *Smo* ^*−/−*^ MEFs (Fig [5](#embr201541532-fig-0005){ref-type="fig"}E).

Phosphorylation of Smo has been implicated in promoting its accumulation within the PC; in the absence of phosphorylation, Smo reportedly fails to localise to the PC of cultured mammalian cells [16](#embr201541532-bib-0016){ref-type="ref"}. We found that GFP‐tagged mSmo localised to the PC of wild‐type zebrafish embryos and that co‐injection of Shh with the mSmo mRNA potentiated this localisation (Fig [6](#embr201541532-fig-0006){ref-type="fig"}A). As expected, the constitutively active mSmoA1 also localised to the PC, but so did mSmoA1SA, mSmoSA, mSmoSD and mSmoKRA (Fig [6](#embr201541532-fig-0006){ref-type="fig"}B). These findings suggest that phosphorylation of the putative GRK2 sites is not required for localisation of Smo to the PC in zebrafish embryos. Moreover, we found that wild‐type mSmo localised normally to the PC in MZ*grk2* embryos, as did the mSmoSA mutant form, indicating ciliary localisation of Smo is also independent of Grk2 activity (Fig [6](#embr201541532-fig-0006){ref-type="fig"}C). In line with this, mSmo also translocated to the PC in response to Shh or SAG in *Grk2* ^−/−^ cells (Fig [EV3](#embr201541532-fig-0003ev){ref-type="fig"}).

![Cilia localisation of wild‐type and mutant Smo\
Wild‐type 18hpf embryos injected with mRNA encoding GFP‐tagged mSmo (green) showing localisation to the PC of myotomal cells labelled with anti‐acetylated tubulin (AcTub; red), stimulated in response to Shh injection (*n* = 4). Differences in PC distribution are due to morphological changes in the myotome induced by ectopic expression of Shh as revealed by the distribution of nuclei (DAPI stained; blue). Scale bar, 10 μm.Notochord cells of wild‐type embryos expressing GFP‐tagged wild‐type and mutant forms of mSmo. Note the localisation to the PC (labelled with anti‐AcTub; red) in each case (*n* = 4 for each sample). Scale bar, 10 μm.MZ*grk2* 18hpf embryos injected with mRNA encoding GFP‐tagged wild‐type mSmo or mSmoSA (green) showing localisation to the PC (labelled with anti‐AcTub; red) in myotomal cells. More Smo is localised to the PC in MZ*grk2* mutants compared to wild type (panel A). Scale bar, 10 μm.](EMBR-17-739-g012){#embr201541532-fig-0006}

![Smo translocates to the primary cilium independently of Grk2\
Accumulation of endogenous Smo in the PC of wild‐type and *Grk2* ^−/−^ Flp‐In‐3T3 cells after 4 h of Shh‐N and SAG treatment. The medians with interquartile range of the fluorescence intensities of endogenous Smo are shown, quantified from multiple cilia (*n* = 150). Data were analysed using Kruskal--Wallis non‐parametric ANOVA. \*\*\*\**P* \< 0.001 and n.s. (not significant).](EMBR-17-739-g007){#embr201541532-fig-0003ev}

Kinase activity is required for Grk2 function in Hh pathway {#embr201541532-sec-0007}
-----------------------------------------------------------

Grk2 has been reported to play both kinase‐dependent and kinase‐independent roles in different processes, including Hh signalling [15](#embr201541532-bib-0015){ref-type="ref"}. Given that phosphorylation of the Smo CTT appears not to be essential for Smo activity in the zebrafish embryo, we next asked whether the kinase activity of Grk2 is dispensable for its function in Hh signalling. Injection of mRNA encoding the archetypal kinase dead form, Grk2^K220R^, was previously reported not to rescue the effects of morpholino‐mediated knock‐down of Grk2 in zebrafish embryos [13](#embr201541532-bib-0013){ref-type="ref"}. We found, however, that injection of this mRNA efficiently rescued both the myotomal expression of Prox1a and Eng and the neural tube expression of *ptch2* and *nkx2.2a* (Figs [7](#embr201541532-fig-0007){ref-type="fig"}B and EV4A). Injection of mRNA encoding two other kinase dead forms of Grk2 (Grk2^K220M^ and Grk2^D335N^) [17](#embr201541532-bib-0017){ref-type="ref"}, [33](#embr201541532-bib-0033){ref-type="ref"} by contrast failed to rescue fully the expression of any of these markers; however, some Prox1a^+ve^ SSFs were restored by Grk2^K220M^ (10 ± 3, *n* = 8) (Fig [7](#embr201541532-fig-0007){ref-type="fig"}B).

![Domains of Grk2 required for Hh pathway activity\
Schematic representation of the zebrafish Grk2 protein showing the location of residues assayed for the effects of their mutation on rescuing activity.Prox1a (green) and Eng (red) expression in the myotome of 30hpf MZ*grk2* embryos that were injected with mRNA encoding: Grk2^K220R^‐GFP; Grk2^K220M^‐GFP; Grk2^D335N^‐GFP; Grk2^ΔN7aa^‐GFP; and mGrk2^L4AV7AL8A^‐GFP. Merged panels show nuclear staining with DAPI in blue (*n* = 20 for each sample). Scale bar, 50 μm.Hh reporter activity assay in wild‐type and *Grk2* ^*−/−*^ 3T3 cells transfected with the equivalent wild‐type and mutant kinase domain forms of mouse Grk2, Grk2^K220R^, Grk2^K220M^ and Grk2^D335N^ after 24‐h Shh‐N and SAG treatment. Data represent the mean and ± SD (*n* = 3). Unpaired Student\'s *t*‐test was used for analysis. \*\*\*\**P* \< 0.0001; \*\**P* \< 0.01; \**P* \< 0.05; and n.s. (not significant).](EMBR-17-739-g013){#embr201541532-fig-0007}

To explore the disparity between the kinase mutants further, we tested their activity in the *Grk2* ^−/−^ cells. The lack of Hh responsiveness of the cells was restored by re‐introducing wild‐type mouse GRK2. The kinase mutants GRK2^K220R^, GRK2^K220M^ and GRK2^D335N^ failed to restore full Hh responsiveness as indicated by absence of luciferase activity compared to wild‐type cells, although GRK2^K220R^‐transfected cells showed an attenuated response to Shh (\~40% compared to wild type), but not to SAG, consistent with GRK2^K220R^ retaining some kinase activity (Fig [7](#embr201541532-fig-0007){ref-type="fig"}C).

The Grk2 domains have been well characterised by structural and functional analyses [34](#embr201541532-bib-0034){ref-type="ref"}; injection of mRNA encoding zebrafish Grk2^∆RGS^, Grk2^∆kinase^ and Grk2^∆PH^ showed that none of these mutant forms of Grk2 can rescue the Hh defects of MZ*grk2* mutants, indicating that each of these domains is essential for Grk2 function in Hh signalling (Fig [EV4](#embr201541532-fig-0004ev){ref-type="fig"}B). The N‐terminal and C‐terminal domains of Grk2 have been shown to be important for interaction with GPCRs and G~βγ~, respectively. Injection of mRNA encoding Grk2^∆CMargin^ completely rescued the Prox1a and Eng expression in the myotome, whereas mRNA encoding Grk2^∆NMargin^ had no activity (Fig [EV4](#embr201541532-fig-0004ev){ref-type="fig"}B). Grk2 has been proposed to interact with GPCRs via an alpha helix in the N‐terminal region of the molecule [35](#embr201541532-bib-0035){ref-type="ref"}; mRNA encoding a smaller deletion of the first seven residues, Grk2^∆N7aa^, or mutations of key amino acids involved with GPCR interaction, Grk2^L4AV7AL8A^ were tested for MZ*grk2* rescue. Grk2^∆N7aa^ failed to rescue the MZ*grk2* phenotype, whereas Grk2^L4AV7AL8A^ partially rescued (Fig [7](#embr201541532-fig-0007){ref-type="fig"}B).

![MZ*grk2* is fully rescued by mRNA encoding Grk2^K220R^ and Grk2 domain swapping assay\
*In situ* hybridisation of *ptch2* and *nkx2.2a* in 24hpf wild‐type (left column) and MZ*grk2* embryos expressing Grk2^K220R^‐GFP (right column) (*n* = 30 for each sample). Scale bar, 200 μm.Prox1a (green) and Eng (red) expression in the myotome of 30hpf MZ*grk2* embryos injected with mRNA encoding Grk2^ΔRGS^‐GFP, Grk2^Δkinase^‐GFP, Grk2^ΔPH^‐GFP, Grk2^ΔCmargin^‐GFP and Grk2^ΔNmargin^‐GFP. Merge images show nuclei labelled with DAPI (blue) (*n* = 20). Scale bar, 50 μm.](EMBR-17-739-g009){#embr201541532-fig-0004ev}

Discussion {#embr201541532-sec-0008}
==========

A role for GRK2 in Hh signalling was first suggested by siRNA‐mediated knock‐down experiments in cultured mammalian cells and validated *in vivo* by morpholino‐mediated knock‐down experiments in zebrafish [12](#embr201541532-bib-0012){ref-type="ref"}, [14](#embr201541532-bib-0014){ref-type="ref"}. The generation and analysis of a zebrafish *grk2* null allele presented here has confirmed an essential requirement for Grk2 in the response of cells to Hh signalling; zebrafish embryos lacking all Grk2 function are devoid of almost all response to Hh activity and resemble embryos homozygous for *smo* null mutations [24](#embr201541532-bib-0024){ref-type="ref"}. In contrast to *smo*, however, the maternal expression of *grk2* is sufficient to support normal embryonic development up to 4dpf. Our findings indicate a more critical requirement for Grk2 activity than has hitherto been appreciated. The mild morphant phenotype in zebrafish embryos together with the moderate reduction in Shh responsiveness of cells elicited by Grk2 siRNA led to the conclusion that GRK2 acts only to potentiate the response of cells to Hh [13](#embr201541532-bib-0013){ref-type="ref"}, [14](#embr201541532-bib-0014){ref-type="ref"}. However, our analysis of both *grk2* embryos and mutant cells reveals that the response to Hh is effectively abolished in the absence of Grk2. Notably, neither zygotic *grk2* nor MZ*grk2* zebrafish embryos show the developmental retardation reported to occur in Grk2 morphants [22](#embr201541532-bib-0022){ref-type="ref"}, suggesting this to be an off‐target effect of the morpholino. This underlines the need for caution in interpreting effects associated with morpholino antisense oligonucleotide injection and the importance of analysing stable transmissible null mutations when characterising gene function. The dramatic loss of Hh signalling observed in the zebrafish MZ*grk2* mutants stands in contrast to the rather mild phenotype of the mouse *Grk2* mutation [14](#embr201541532-bib-0014){ref-type="ref"}, which might be explained by partial redundancy between *Grk2* and the paralogous *Grk3* gene. Notably, our *Grk2* ^−/−^ cells, which show a strong loss of Shh responsiveness, do not express Grk3 (Fig [EV5](#embr201541532-fig-0005ev){ref-type="fig"}).

![Grk3 is not expressed in NIH3T3 cells\
RT--PCR assay of Grk2 and Grk3 expression in MEF and NIH 3T3 cells.](EMBR-17-739-g011){#embr201541532-fig-0005ev}

Several analyses have led to the conclusion that the principal role of Grk2 in Hh signalling is to potentiate activity of Smo by phosphorylating its CTT [15](#embr201541532-bib-0015){ref-type="ref"}, [16](#embr201541532-bib-0016){ref-type="ref"}, [17](#embr201541532-bib-0017){ref-type="ref"}. In *Drosophila*, although PKA is primarily responsible for Smo phosphorylation, CK1 and Gprk2 have also been implicated in this process [15](#embr201541532-bib-0015){ref-type="ref"}, [17](#embr201541532-bib-0017){ref-type="ref"}, [36](#embr201541532-bib-0036){ref-type="ref"}. *Drosophila* and vertebrate Smo have divergent CTTs, and the PKA phosphorylation sites are not found in vertebrate Smo. The phosphorylation is postulated to neutralise the positive charge of the lysine/arginine cluster in the CTT, causing a conformational change that promotes dimerisation and ciliary localisation, activating Smo [16](#embr201541532-bib-0016){ref-type="ref"}. Our *in vivo* data challenge this model: first, SmoSA as well as Smo14SA, which lacks all the predicted phosphorylation sites, fully rescued the *smo* mutant phenotype. Second, mutation of the phosphorylation sites in the SmoA1 gain of function mutant attenuated but did not abolish its constitutive activity. Third, the phosphomimetic SmoSD mutant, while remaining responsive to Hh, lacked constitutive activity in zebrafish embryos. Finally, the SmoKRA mutant, in which the CTT lysine/arginine residues are replaced with alanine, showed no evidence of constitutive activity. In addition, we found that wild‐type Smo and SmoSA localised to the PC both in wild‐type and in *grk2* mutant embryos. Based on these findings, we conclude that phosphorylation of the CTT, at least at the predicted GRK2/CK1 sites, is dispensable for Smo localisation and neither necessary nor sufficient for Smo activation. Our findings that the SmoSD and SmoKRA mutants lack constitutive activity in MEFs, together with the ability of Smo to localise to the PC of *Grk2* ^−/−^ cells, support this conclusion. On the other hand, the finding that SmoSA mutant lacked activity in the MEF assay is in line with previous reports [16](#embr201541532-bib-0016){ref-type="ref"}, and consistent with phosphorylation of the GRK2/CK1 sites being necessary, if not sufficient, for Smo activity, at least in these mammalian cells. Why there should be a difference in the requirement for these sites between zebrafish and mammals is unclear, though such differences in Hh pathway activity between zebrafish and mammals are not unprecedented; the serine--threonine kinase, STK36, for instance, has been shown to be required for efficient Hh signal transduction in zebrafish yet is dispensable for the response to Hh in mouse [37](#embr201541532-bib-0037){ref-type="ref"}, [38](#embr201541532-bib-0038){ref-type="ref"}. Direct analysis of the phosphorylation status of Smo in wild‐type and *grk2* mutant zebrafish and mouse embryos will be required to shed further light on this issue.

Previous studies in *Drosophila* have concluded that Gprk2 plays both kinase‐dependent and kinase‐independent roles in the response of cells to Hh activity, a conclusion based on the ability of the K220M kinase domain mutant to effect a partial rescue of the *gprk2* mutant phenotype in the wing imaginal disc [15](#embr201541532-bib-0015){ref-type="ref"}. In line with this, we found that the same mutant form of Grk2 could partially rescue the MZ*grk2* mutant phenotype in zebrafish. More surprisingly, the archetypal K220R "kinase dead" mutant effected a complete rescue of the MZ*grk2*, contrary to the previous report that it could not rescue the *grk2* morphant phenotype. This latter finding could reflect the conservative nature of this mutation, the positively charged lysine residue, essential for interaction with the alpha/beta phosphate of ATP [39](#embr201541532-bib-0039){ref-type="ref"}, [40](#embr201541532-bib-0040){ref-type="ref"}, being replaced by a similarly positively charge arginine residue, which might thereby result in the mutant form retaining significant catalytic activity. On the other hand, we found that the Grk2^D335N^ mutant form completely failed to rescue the MZ*grk2* mutant; while this implies that the kinase domain is essential for all responses to Hh activity, we cannot exclude the possibility that this substitution also disrupts some other aspect of Grk2 function.

If Grk2 does not function by activating Smo, what then is its target? Our findings are consistent with a role for Grk2 in controlling the trafficking of a G‐protein‐coupled receptor (GPCR): first, the kinase activity is required for Grk2 function in Hh pathway; second, loss of the N‐terminal region of Grk2, involved in interaction with GPCR, abolishes its rescuing activity. Recent studies have implicated several orphan GPCRs in modulation of the Hh pathway via classical G‐protein signalling mechanisms [8](#embr201541532-bib-0008){ref-type="ref"}, [9](#embr201541532-bib-0009){ref-type="ref"}: in the neural tube, for instance, GPR161 suppresses Hh pathway activity promoting cAMP production via the Gαs--adenylate cyclase pathway; this in turn leads to activation of PKA, thereby promoting the production of the repressor forms of Gli. Hh pathway activation counters this effect by promoting internalisation of GPR161, leading to a decrease in cellular cAMP levels and hence a reduction in PKA activity [8](#embr201541532-bib-0008){ref-type="ref"}. It is tempting to speculate that this GPCR could be a target of Grk2. Testing this hypothesis will require the generation of mutations in the two zebrafish GPR161 orthologues.

Materials and Methods {#embr201541532-sec-0009}
=====================

Zebrafish strains and husbandry {#embr201541532-sec-0010}
-------------------------------

Adult fish were maintained on a 14‐h light/10‐h dark cycle at 28°C in the AVA (Singapore)‐certificated IMCB Zebrafish Facility. Zebrafish strains used were *grk2* ^*i283*^ (this study); *smo* ^*hi1640*^ [31](#embr201541532-bib-0031){ref-type="ref"}; *Tg(Eng2a:eGFP)* ^i233^ [41](#embr201541532-bib-0041){ref-type="ref"}.

Generation, selection and genotyping of zebrafish mutant alleles {#embr201541532-sec-0011}
----------------------------------------------------------------

Plasmids encoding zinc finger nuclease (ZFN) were synthesised by ToolGen, Korea. Capped mRNA was produced using mMessage mMachine kit according to the manufacturer\'s protocol and injected into 1‐cell stage embryos at a dose of 100 pg per embryo. G0 adults derived from embryos injected with ZFN mRNA were in‐crossed and their progenies were individually genotyped by PCR using the forward primer (5′‐CTC TCT CGC GCA TCA ACA TCA TCA TCT‐3′) and the reverse primer (5′‐GGT GAA CTA GCT CTT TAT TAC TGA ACA‐3′) followed by Sanger sequencing using primer (5′‐CTG GCT GGA CTC GGT GCT GGT GT‐3′). Founders transmitting a single allele (*grk2* ^*i283*^, 111delC) were selected and used to establish mutant line.

The *smo* ^*hi1640*^ mutant allele was genotyped by PCR using the forward primer (5′‐CTA CTT TGT TGC GTC TCC AAG ATG TC‐3′) and the reverse primer (5′‐GAG GGT CTC CTC TGA GTG ATT GAC TAC‐3′). Homozygous mutants were identified by the presence of *smo* ^*hi1640*^ mutant allele and the absence of the wild‐type allele using the same forward primer as before and a reverse primer (5′‐CCA GAC CAC ATG GCC AAT TTC TCG‐3′).

Generation of MZ*grk2* by germ cell replacement {#embr201541532-sec-0012}
-----------------------------------------------

Germ cell replacement was performed as described [23](#embr201541532-bib-0023){ref-type="ref"}. In brief, donor embryos from a *grk2* ^*i283/*+^ × *grk2* ^*i283/*+^ in‐cross were labelled by injecting GFP‐*nanos*‐3′UTR RNA [42](#embr201541532-bib-0042){ref-type="ref"}. Wild‐type host embryos were injected with morpholino antisense oligonucleotide against *dead end* (5′‐GCT GGG CAT CCA TGT CTC CGA CCA T‐3′) to block germ cell development [43](#embr201541532-bib-0043){ref-type="ref"}. Cells were transplanted from donors (dome stage) into hosts at the same stage. Donor embryos were genotyped by PCR using the primers described above. Transplanted host embryos were screened at 24hpf for successful transfer of donor germ cells indicated by GFP expression [23](#embr201541532-bib-0023){ref-type="ref"}.

Cell lines {#embr201541532-sec-0013}
----------

Flp‐In‐3T3 and 293FT cells (Life Technologies) were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM) containing high glucose (Thermo Scientific) and supplemented with 10% foetal bovine serum (FBS) (Atlanta Biologicals), 1 mM sodium pyruvate, 2 mM [l]{.smallcaps}‐glutamine, 1× MEM non‐essential amino acids solution, penicillin (40 U/ml) and streptomycin (40 μg/ml), in a humidified atmosphere containing 5% CO~2~ at 37°C. Experiments in *Smo* ^*−/−*^ MEFs were performed as previously described [44](#embr201541532-bib-0044){ref-type="ref"}. To induce ciliation, cells were grown to confluence in medium containing 10% FBS and then switched to medium containing 0.5% FBS with Hh pathway agonists (SHH‐N and 200 nM SAG) for 24 h (for reporter assays and Western blotting) and 4 h (for Smo immunofluorescence staining). SHH‐N‐conditioned media was generated as previously described [45](#embr201541532-bib-0045){ref-type="ref"}.

Generation of *Grk2* ^*−/−*^ cells {#embr201541532-sec-0014}
----------------------------------

Flp‐In‐3T3 *Grk2* ^*−/−*^ cells were generated by CRISPR‐Cas9 gene editing technology as previously described [46](#embr201541532-bib-0046){ref-type="ref"}. Briefly, guide RNA sequences targeting *Grk2* (guide‐1: 5′‐AAT GCT ACG GAG CAT GTC C‐3′; guide‐2: 5′‐CTG GAA CAC GTC CCC TCG G‐3′; guide‐3: 5′‐TCA GTG TGC ATC GAA TCA T‐3′; guide‐4: 5′‐TGC ATC GAA TCA TCG GGC GT‐3′) were cloned into lentiCRISPR v2 plasmid (Addgene\#52961). To produce lentivirus, 293FT (3 × 10^6^ cells) seeded in 10‐cm plates were transfected with 8 μg lentiCRISPR v2 plasmid, 4 μg pCMV‐VSV‐G (Addgene\#8454), 4 μg psPAX2 (Addgene\#12260) and 48 μl of 1 mg/ml polyethylenimine (Polysciences). Lentivirus was collected 60 h posttransfection and filtered using a 0.45‐μm low‐protein binding membrane (Pall Corporation). Flp‐In‐3T3 cells were transduced twice with the lentivirus for 48 h and later selected in puromycin‐containing DMEM (2 μg/ml) for 10 days.

Hh reporter assays {#embr201541532-sec-0015}
------------------

Flp‐In‐3T3 wild‐type and *Grk2* ^*−/−*^ (lentiCRISPR guide‐2) cells were seeded in 96‐well plates and transfected using X‐tremeGENE 9 (Roche) following manufacturer\'s instructions. The transfection mix consisted of a 4:1 w/w ratio of a firefly luciferase reporter driven by an 8x*Gli*‐responsive promoter and a Renilla luciferase reporter driven by a constitutive TK promoter (Promega) along with a vector control and GRK2, mSmoA1 and YF‐PKI/PKI‐M. Cells were grown to confluence and then serum‐starved for 24 h with SHH‐N (used at 1:4 dilution of the conditioned media) and SAG (200 nM). SHH‐N‐conditioned media was produced using HEK293 cells [45](#embr201541532-bib-0045){ref-type="ref"}. Reporter activity was measured using the Dual‐Luciferase Reporter kit (Promega) and read on a Synergy H1 Hybrid Multi‐Mode Microplate Reader (BioTek). The GLI luciferase to Renilla luciferase ratio is reported as "Hh reporter activity".

*In situ* hybridisation and immunofluorescence {#embr201541532-sec-0016}
----------------------------------------------

Standard *in situ* hybridisation was performed with anti‐Dig alkaline phosphatase and chromogenic substrate NBT/BCIP as previously described [47](#embr201541532-bib-0047){ref-type="ref"}. RNA probes were prepared from templates as previously described: *ptch2* (formerly *ptc1*) [48](#embr201541532-bib-0048){ref-type="ref"}, *nkx2.2a* [49](#embr201541532-bib-0049){ref-type="ref"} and *olig2* [50](#embr201541532-bib-0050){ref-type="ref"}.

Whole‐mount antibody staining was performed as previously described at the following dilutions: mAb4D9 (anti‐Engrailed, DSHB) at 1:50 [26](#embr201541532-bib-0026){ref-type="ref"}; rabbit anti‐Prox1a at 1:5,000 (Millipore); mouse anti‐acetylated α‐tubulin at 1:500 (Sigma); chicken anti‐GFP at 1:500 (Abcam) [51](#embr201541532-bib-0051){ref-type="ref"}. The secondary antibodies were as follows: Alexa488‐conjugated donkey anti‐mouse, anti‐rabbit and anti‐chicken, Alexa546‐conjugated donkey anti‐mouse and anti‐rabbit, Alexa647‐conjugated donkey anti‐mouse and anti‐rabbit secondary antibodies (1:1,000, Invitrogen). Rabbit polyclonal antibodies against mouse Smo were used for the detection of ciliary localisation of Smo in Flp‐In‐3T3 cells as previously described [6](#embr201541532-bib-0006){ref-type="ref"}. Ciliary Smo quantifications were done as previously described [52](#embr201541532-bib-0052){ref-type="ref"}. Prox1a^+ve^ cells were counted in 3--5 somites from 4 to 10 embryos rostral to the end of yolk extension.

Protein analysis {#embr201541532-sec-0017}
----------------

Standard Western blotting on fish embryo lysates was performed as previously described [53](#embr201541532-bib-0053){ref-type="ref"}. Primary antibodies used were as follows: rabbit anti‐zebrafish Gli2a (1:5,000) [41](#embr201541532-bib-0041){ref-type="ref"}; mouse anti‐γ‐tubulin at 1:5,000 (Sigma); mouse anti‐myc 1:2,000 (9E10, Santa Cruz Biotechnology, Inc); rabbit anti‐GRK3 1:2,500 (sc‐563, raised against C‐terminal of bovine Grk3; Santa Cruz Biotechnology, Inc) [14](#embr201541532-bib-0014){ref-type="ref"}; mouse anti‐GFP 1:3,000 (632569, Clontech); and mouse anti‐Myc 1:3,000 (Santa Cruz Biotechnology, Inc). The secondary antibodies were HRP‐conjugated goat anti‐mouse and anti‐rabbit at 1:20,000. Western blotting on cell lines was performed as previously described [52](#embr201541532-bib-0052){ref-type="ref"}, using the following antibodies: mouse anti‐Grk2 antibody (sc‐13143, raised against 468--689 of human GRK2; Santa Cruz Biotechnology); mouse anti‐GLI1 antibody (2643, Cell Signaling); goat anti‐GLI3 antibody (AF3690, R&D); mouse anti‐α‐tubulin antibody (T6199, Sigma); and rabbit anti‐PTCH1 [6](#embr201541532-bib-0006){ref-type="ref"}.

To test the stability of Smo, 600 pg mRNA of the bicistronic Smo P2A construct was injected. Approximately 100 embryos were harvested at 18hpf and deyolked as previously described [53](#embr201541532-bib-0053){ref-type="ref"}. About 0.5 μl of PBS with proteinase inhibitor was added per embryo. Vigorous pipetting was used to lyse the cells. Lysates were incubated on ice for 30 min with occasional vigorous pipetting. Lysates were spun down at 16,200 *g* for 15 min, and the supernatant was removed for GFP Western blot analysis. The pellet‐containing insoluble Smo was washed once with PBS and solubilised with 50 mM Tris pH 6.8, 1% Triton X‐100 and 8 M urea. Insoluble material was removed by centrifuging at 16,200 *g* for 15 min, and the supernatant was used for Myc Western blot analysis. Extract from approximately 40 embryos was loaded in each well. The intensity of Myc and GFP signal was quantified using ImageJ. Mutant Smo stability was assessed by normalising the Myc/GFP intensity ratio against wild‐type Smo.

DNA constructs, synthetic RNA synthesis, morpholinos and microinjection {#embr201541532-sec-0018}
-----------------------------------------------------------------------

Wild‐type and all mutant forms of zebrafish *grk2* and mouse *Smo* were tagged with GFP at their C‐termini and cloned into *pCS2+* vector. To test Smo stability, a bicistronic *Smo* was Myc‐tagged at its C‐terminus followed by a self‐cleaving P2A peptide sequence and GFP. Capped mRNA was synthesised using the SP6 mMessage mMachine Kit (Ambion), using plasmids linearised by NotI. *shh* and *dnPKA* mRNA for injection were synthesised as described [48](#embr201541532-bib-0048){ref-type="ref"}. For *smo,* 500 pg of mRNA was injected. For transient knock‐down of zGrk2, 1 nl of the 0.1 mM ATG antisense morpholino: 5′‐AGG TCC GCC ATC TTC GCC CTC TGG G‐3′ (synthesised by Gene Tools, Philomath, OR), was injected into embryos at the 1‐cell stage as previously described [14](#embr201541532-bib-0014){ref-type="ref"}. To test the activity of wild‐type and mutant forms of GRK2 in cell lines, mouse *Grk2* was tagged with a C‐terminal GFP and cloned into *pEF5/FRT/V5‐DEST* (Life Technologies). YF‐PKI and YF‐PKI‐M were kindly provided by Dr. Takanari Inoue (Johns Hopkins University, USA). To test the activity of mutant forms of Smo in *Smo* ^*−/−*^ MEFs, the same constructs used for generating mRNA were used.

Quantitative RT--PCR and RT--PCR {#embr201541532-sec-0019}
--------------------------------

RNA was isolated from 30 embryos at the 18 somite stage (ss) using Trizol (Invitrogen). Two milligrams of RNA was then used for generating cDNA using SuperScript III reverse transcriptase (Invitrogen) and oligodT primers (Fermentas). About 0.2 μl of cDNA was used for the qPCR (Kapa Sybr Fast Universal qPCR kit, Kapa Biosystem). Normalisation was done against β‐actin, and primers used for the quantification of β‐actin and Patched2 are as follows: *actin* F: 5′‐CTC TTC CAG CCT TCC TTC CT‐3′; *actin* R: 5′‐CAC CGA TCC AGA CGG AGT AT‐3′; *ptch2* F: 5′‐CCT GGT GTG TGC CAT CCT CCT G‐3′; and *ptch2* R: 5′‐TCC ATA GCA ACG GCT GAA CGA G‐3′. RNA of tissue culture and cDNA was prepared as described above. One microlitre of cDNA was used for RT--PCR. The m*Grk2* primers are F: 5′‐GCT CAG GAG GTA AAA GAA AGT CC‐3′ R: 5′‐CGT TCC TTG ATC TGT GTC TCT TC‐3′; and the mGrk3 primers are F: 5′‐GGC AGC ATA AAA CCA AAG ACA AG‐3′ R: 5′‐TAG CGT AAT CTT CCT CTT GAC CA‐3′.
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